MedTrace Logo

Spectral CT Combined With MSI for Predicting Regional Lymph Node Metastasis in Gastric Cancer

NCT07565818 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2026-05-04

No results posted yet for this study

Summary

This study prospectively collected spectral CT imaging data and clinical information related to gastric cancer, evaluated the diagnostic efficacy of its image quality for regional lymph nodes in gastric cancer, and explored its application value in the N staging of gastric cancer with different MSI statuses, so as to provide a more accurate evidence for clinical diagnosis, promote the development of individualized treatment for gastric cancer, and ultimately improve the prognosis of patients.

Conditions

Interventions

DIAGNOSTIC_TEST

o explore the value of spectral CT in the diagnosis and treatment of gastric cancer with different MSI statuses

Abdominal CT scans were performed in addition to conventional treatment regimens

Sponsors & Collaborators

  • Yunnan Cancer Hospital

    lead OTHER

Principal Investigators

  • Ye Lianhua, Study Director · Ethics Committee of Yunnan Provincial Cancer Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-04
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07565818 on ClinicalTrials.gov